Cathie Wood
GLMD icon

Cathie Wood’s Galmed Pharmaceuticals GLMD Stock Holding History

Cathie Wood’s Portfolio GLMD Stock Details GLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-161
Closed -$1.11M – 226
2020
Q2 		$1.11M Buy
161
+100
+164% +$675K 0.01% 154
2020
Q1 		$305K Sell
61
-2
-3% -$15.2K 0.01% 156
2019
Q4 		$525K Buy
63
+13
+26% +$89.3K 0.01% 131
2019
Q3 		$347K Buy
50
+8
+19% +$64.2K 0.01% 178
2019
Q2 		$448K Buy
42
+5
+14% +$51.6K 0.01% 146
2019
Q1 		$439K Buy
37
+9
+32% +$105K 0.01% 147
2018
Q4 		$279K Buy
28
+3
+12% +$41.9K 0.01% 146
2018
Q3 		$487K Buy
+25
New +$468K 0.01% 147

Other funds holding GLMD

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $194M AUM 23.58% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
PAWC
P.A.W. Capital Greenwich, Connecticut $131M AUM 46.14% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Cathie Wood's GLMD Position: Q3 2020 in Review

Cathie Wood sold out of Galmed Pharmaceuticals (GLMD) in Q3 2020, closing a stake of 161 shares — an estimated $1.11M sold.

Cathie Wood first reported a position in GLMD in Q3 2018 and held it in 8 quarters. The position peaked at $1.11M in Q2 2020. 20 funds tracked by Wall St. Rank hold GLMD as of Q3 2020.

  • Cathie Wood reported no remaining Galmed Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Cathie Wood sold 161 Galmed Pharmaceuticals shares in Q3 2020, an estimated $1.11M.
  • Cathie Wood first reported a position in Galmed Pharmaceuticals in Q3 2018 and held it in 8 quarters.
  • Cathie Wood's Galmed Pharmaceuticals position peaked at $1.11M in Q2 2020.
  • 20 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q3 2020.

Based on ARK Investment Management's 13F filing for Q3 2020, filed 30 Oct 2020.